Drug-related adverse events potentially predict the efficacy of apatinib on advanced hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide every year, and most HCC patients are diagnosed with advanced disease and can only receive systemic treatment. TKIs are the most important components of the systemic treatment of HCC and have bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiaoying, Zhang, Su, Yang, Xuejiao, Guan, Tao, Hou, Zhenyu, Cao, Manqing, Li, Huikai, Zhang, Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620633/
https://www.ncbi.nlm.nih.gov/pubmed/36316630
http://dx.doi.org/10.1186/s12876-022-02542-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620633/
https://www.ncbi.nlm.nih.gov/pubmed/36316630
http://dx.doi.org/10.1186/s12876-022-02542-0

Ejemplares similares